EverSource Wealth Advisors’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146K Sell
8,217
-3,301
-29% -$52K ﹤0.01% 1187
2026
Q1
$165K Buy
11,518
+3,946
+52% +$65.5K 0.01% 1159
2025
Q4
$134K Buy
7,572
+4,038
+114% +$66.8K ﹤0.01% 1162
2025
Q3
$55.6K Buy
3,534
+246
+7% +$3.45K ﹤0.01% 1625
2025
Q2
$36.6K Buy
3,288
+2,935
+831% +$34.4K ﹤0.01% 1833
2025
Q1
$4.12K Buy
353
+2
+0.6% +$26 ﹤0.01% 2588
2024
Q4
$4.8K Buy
351
+146
+71% +$2.12K ﹤0.01% 2365
2024
Q3
$3.42K Buy
205
+24
+13% +$351 ﹤0.01% 2366
2024
Q2
$2.51K Buy
181
+164
+965% +$1.87K ﹤0.01% 2475
2024
Q1
$190 Sell
17
-165
-91% -$2.46K ﹤0.01% 2802
2023
Q4
$3.07K Buy
+182
New +$2.58K ﹤0.01% 2044
2022
Q3
Sell
-195
Closed -$4K 2117
2022
Q2
$4K Buy
+195
New +$4.08K ﹤0.01% 1344
2022
Q1
Sell
-63
Closed -$1K 1830
2021
Q4
$1K Buy
+63
New +$1.51K ﹤0.01% 1725

Other funds holding SHC

EverSource Wealth Advisors's SHC Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Sotera Health (SHC) stake by 29% in Q2 2026, selling an estimated $52K and leaving 8,217 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

EverSource Wealth Advisors first reported a position in SHC in Q4 2021 and has held it in 13 quarters since. The position peaked at $165K in Q1 2026. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • EverSource Wealth Advisors held 8,217 shares of Sotera Health worth $146K as of Q2 2026.
  • EverSource Wealth Advisors sold 3,301 Sotera Health shares in Q2 2026, an estimated $52K.
  • Sotera Health made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1187 holding.
  • EverSource Wealth Advisors first reported a position in Sotera Health in Q4 2021 and has held it in 13 quarters since.
  • EverSource Wealth Advisors's Sotera Health position peaked at $165K in Q1 2026.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.